Targeting Hypoxia: Hypoxia-Activated Prodrugs in Cancer Therapy

Overview of attention for article published in Frontiers in oncology, July 2021

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (67th percentile)
High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

twitter: 2 X users

wikipedia: 1 Wikipedia page

Citations

dimensions_citation: 71 Dimensions

Readers on

mendeley: 94 Mendeley

Summary X Wikipedia Dimensions citations

So far, Altmetric has seen 1 Wikipedia article.

English

Evofosfamide

Cited by user Tahreemasghar on 09 May 2022

Evofosfamide (INN, USAN; formerly known as TH-302) is an investigational hypoxia-activated prodrug that is in clinical development for cancer treatment.

This page shows the most recent Wikipedia articles that mention this research output.

Click here to find out how to access more activity.